We previously showed that t(8;21) fusion protein acute myeloid leukemia (AML)1–ETO and its alternatively spliced variant AML1–ETO9a (AE9a) enhance the JAK/STAT pathway via downregulation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback